Really important morning session on how to build the transplant fellowship work force across all organs- timely initiative - early exposure, mentorship, impact of work, work life resources all very important area of focus @ast-licop.bsky.social #WTC2025

Thank you for highlighting our paper @atoosarabiee.bsky.social If you want some light liver cancer learning ;)

🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥 👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm 👉great news for our patients > more options in 1st line 😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA @myESMO @EASLedu @ILCAnews #livertwitter

Spicy! Adding lasix to the management of hepatorenal syndrome might be ok if you bump the MAP with pressors @juancarlosqvelez.bsky.social doi.org/10.1016/j.ek... #nephsky #liversky

Join ACG for the next Virtual Grand Rounds— ACG Clinical Guideline: Focal Liver Lesions Reena J. Salgia, MD Thursday, February 27 at Noon & 8pm ET ➡️ gi.org/ACGVGR

Every year I feel so fortunate to be part of this #LiverCancer community with these amazing friends who are true leaders sharing a common goal!! Amongst the beautiful chaos that is life, it’s important to find your passion and your people 💚. That’s a wrap @hcclive.bsky.social

Registration is now open! We're so excited to welcome you to the 2025 HCC-LIVE Conference. See you at the Welcome Reception at 6:30!

Seems like a good time to re-share my essay which has a whole section titled, “What, even, is ‘DEI’?” arghavan.substack.com/p/dei-isnt-r...

Kirema Garcia-Reyes is giving a Critical Assessment of EMERALD -1 at HCC Live! Make sure to attend this session for a review of data, treatment efficacy, and safety findings from the EMERALD-1 clinical study @kiremagarciamd

Join the Debate: Drs. Riad Salem and Mishal Mendiratta-Lala Face Off on Histosonics vs. SBRT! Don’t miss this compelling discussion and more at HCC Live. Enjoy 40% off registration until January 31st! 👉 Register now: loom.ly/7h0SJyM

Dr. Tanios Bekaii- Saab is presenting at HCC Live! You wont want to miss this. Register now at loom.ly/7h0SJyM.

Course Director Spotlight: Join Anjana Pillai, MD at the HCC-LIVE Conference - Space is Limited - Register Now! @anjanapillaimd.bsky.social

Read this A review of reported adverse events for medications to treat alcohol use disorder we must reduce alcohol use in people with liver disease And to increase uptake of useful tools … we need stop repeating that naltrexone is hepatotoxic doi.org/10.1016/j.cg...

Hello #livertwitter friends- if you’re a liver cancer expert or want to be, please join us Feb 20-22 in Austin! We’d love to see you there! www.hcc-live.org @hcclive.bsky.social

🎊Happy Holidays from your #HCC-LIVE conference crew! We are excited to see our fellow #livercancer enthusiasts in Austin Feb 20-22. We’d love for you to join our growing community!! Also submit your abstracts by 12/27 loom.ly/UBi8KDc

Really good review for those of us who are not always digging into statistical methods #livertwitter evidence.nejm.org/doi/full/10....

🎉Happy holidays my fellow liver lovers I’m sure many of you have seen this but thought I’d leave this right here 😉🎁 www.instagram.com/share/BAEBdk...

Systematic review & meta-analysis of locoregional therapies for #HCC in @jama.com network open ✅Inclusion: RCTs with PFS and OS as endpoints ✅Conclusions: Resection > thermal ablation ~ RT ~ HAIC > embolization #oncsky #radonc #radsky #liversky ja.ma/3ONRpQ1